Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-12-22

Clinical Trial Update: Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey

View source ↗

Summary

This clinical trial update reports patients' opinions on switching to a single-pill fixed-dose combination of tenofovir, emtricitabine, and efavirenz for HIV in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate)

Snippet

Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland | Conditions: HIV Infection | Status: COMPLETED